George Simeon

CIK 000159511710 companiesCONSHOHOCKEN, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001595117

Recent Transactions

50 trades

Purchase
Zenas BioPharma, Inc.$ZBIO
Common Stock
2025-10-09$19.00/sh+63,157→ 1,917,895 total
Purchase
Zenas BioPharma, Inc.$ZBIO
Common Stock
2025-10-09$19.00/sh+63,158→ 1,173,395 total
Purchase
CRISPR Therapeutics AG$CRSP
Common Shares
2025-07-16$52.03/sh+6,510→ 69,687 total
Purchase
CRISPR Therapeutics AG$CRSP
Common Shares
2025-07-16$52.03/sh+960,983→ 1,730,179 total
Purchase
CRISPR Therapeutics AG$CRSP
Common Shares
2025-07-16$52.03/sh+22,319→ 238,897 total
Award
Design Therapeutics, Inc.$DSGN
Stock Option (right to buy)
2025-06-10+19,000→ 19,000 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2025-06-05+13,000→ 13,000 total
Award
Nkarta, Inc.$NKTX
Stock Option (right to buy)
2025-06-05+46,000→ 46,000 total
Conversion
Zenas BioPharma, Inc.$ZBIO
Series C Convertible Preferred Stock
2024-09-16−13,071,439→ 0 total
Conversion
Zenas BioPharma, Inc.$ZBIO
Series C Convertible Preferred Stock
2024-09-16−4,357,146→ 0 total
Purchase
Zenas BioPharma, Inc.$ZBIO
Common Stock
2024-09-16$17.00/sh+441,176→ 1,946,564 total
Conversion
Zenas BioPharma, Inc.$ZBIO
Common Stock
2024-09-16+501,796→ 501,796 total
Conversion
Zenas BioPharma, Inc.$ZBIO
Common Stock
2024-09-16+669,061→ 669,061 total
Conversion
Zenas BioPharma, Inc.$ZBIO
Series C Convertible Preferred Stock
2024-09-16−5,809,528→ 0 total
Purchase
Zenas BioPharma, Inc.$ZBIO
Common Stock
2024-09-16$17.00/sh+1,352,942→ 1,854,738 total
Conversion
Zenas BioPharma, Inc.$ZBIO
Common Stock
2024-09-16+1,505,388→ 1,505,388 total
Purchase
Zenas BioPharma, Inc.$ZBIO
Common Stock
2024-09-16$17.00/sh+441,176→ 1,110,237 total
Award
Nkarta, Inc.$NKTX
Stock Option (right to buy)
2024-06-13+22,500→ 22,500 total
Award
Design Therapeutics, Inc.$DSGN
Stock Option (right to buy)
2024-06-13+19,000→ 19,000 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to buy)
2024-05-30+13,000→ 13,000 total
Purchase
Nkarta, Inc.$NKTX
Common Stock
2024-03-27$10.00/sh+451,659→ 451,659 total
Purchase
Nkarta, Inc.$NKTX
Common Stock
2024-03-27$10.00/sh+1,548,341→ 1,548,341 total
Award
CRISPR Therapeutics AG$CRSP
Common Shares
2024-02-27$71.50/sh+216,578→ 216,578 total
Award
CRISPR Therapeutics AG$CRSP
Common Shares
2024-02-27$71.50/sh+63,177→ 63,177 total
Award
CRISPR Therapeutics AG$CRSP
Common Shares
2024-02-27$71.50/sh+769,196→ 769,196 total
Sale
eFFECTOR Therapeutics, Inc.
Common Stock
2023-11-27$0.61/sh−178,585→ 1,821,415 total
Sale
eFFECTOR Therapeutics, Inc.
Common Stock
2023-11-27$0.61/sh−430,578→ 4,391,536 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2023-06-08+13,000→ 13,000 total
Award
Nkarta, Inc.$NKTX
Stock Option (right to buy)
2023-06-07+22,500→ 22,500 total
Award
Design Therapeutics, Inc.$DSGN
Stock Option (right to buy)
2023-05-31+15,000→ 15,000 total
Sale
Arcellx, Inc.$ACLX
Common Stock
2023-05-11$46.15/sh−3,804→ 1,658,780 total
Sale
Arcellx, Inc.$ACLX
Common Stock
2023-05-11$46.15/sh−6,485→ 2,828,394 total
Sale
Arcellx, Inc.$ACLX
Common Stock
2023-05-11$45.00/sh−370,612→ 1,662,584 total
Sale
Arcellx, Inc.$ACLX
Common Stock
2023-05-11$45.00/sh−631,932→ 2,834,879 total
Purchase
Design Therapeutics, Inc.$DSGN
Common Stock
2022-12-20$8.14/sh+40,000→ 6,526,476 total
Purchase
Design Therapeutics, Inc.$DSGN
Common Stock
2022-12-19$8.63/sh+360,000→ 6,486,476 total
Purchase
Design Therapeutics, Inc.$DSGN
Common Stock
2022-12-16$8.28/sh+500,000→ 6,126,476 total
Disposition to Issuer
Turning Point Therapeutics, Inc.
Common Stock
2022-08-17$76.00/sh−2,253,660→ 0 total
Disposition to Issuer
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2022-08-17−15,000→ 0 total
Disposition to Issuer
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2022-08-17−8,500→ 0 total
Disposition to Issuer
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2022-08-17−8,500→ 0 total
Award
Design Therapeutics, Inc.$DSGN
Stock Option (right to buy)
2022-06-15+15,000→ 15,000 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2022-06-09+12,000→ 12,000 total
Award
Nkarta, Inc.$NKTX
Stock Option (right to buy)
2022-06-08+16,000→ 16,000 total
Purchase
Nkarta, Inc.$NKTX
Common Stock
2022-04-28$15.00/sh+666,667→ 666,667 total
Purchase
Nkarta, Inc.$NKTX
Common Stock
2022-04-28$15.00/sh+666,666→ 666,666 total
Purchase
Arcellx, Inc.$ACLX
Common Stock
2022-02-08$15.00/sh+1,600,000→ 2,033,196 total
Conversion
Arcellx, Inc.$ACLX
Series C Preferred Stock
2022-02-08−433,196→ 0 total
Conversion
Arcellx, Inc.$ACLX
Series A Preferred Stock
2022-02-08−1,550,309→ 0 total
Purchase
Arcellx, Inc.$ACLX
Common Stock
2022-02-08$15.00/sh+66,667→ 3,466,811 total

George Simeon

Recent Transactions

Companies

Recent Filings

Address